1995
DOI: 10.1016/0264-410x(94)00055-r
|View full text |Cite
|
Sign up to set email alerts
|

Immunological responses and protection against Mycobacterium bovis in calves vaccinated with a low dose of BCG

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

16
194
1
1

Year Published

2001
2001
2019
2019

Publication Types

Select...
6
2
2

Relationship

0
10

Authors

Journals

citations
Cited by 222 publications
(212 citation statements)
references
References 26 publications
16
194
1
1
Order By: Relevance
“…These results are similar to those of previous studies using cattle experimentally infected with M. bovis and cattle vaccinated with M. bovis bacillus Calmette-Guérin (BCG). [4][5][6][7]12,18 In cattle experimentally infected with M. bovis, OD values were elevated following the CFT (0.1 ml of 3 mg bovine PPD/ml) and did not return to pre-skin test levels within the 59-day study period. 12,18 Likewise, a boost in ␥-IFN production was observed 14 days after the CCT in experimentally infected cattle.…”
Section: Discussionmentioning
confidence: 99%
“…These results are similar to those of previous studies using cattle experimentally infected with M. bovis and cattle vaccinated with M. bovis bacillus Calmette-Guérin (BCG). [4][5][6][7]12,18 In cattle experimentally infected with M. bovis, OD values were elevated following the CFT (0.1 ml of 3 mg bovine PPD/ml) and did not return to pre-skin test levels within the 59-day study period. 12,18 Likewise, a boost in ␥-IFN production was observed 14 days after the CCT in experimentally infected cattle.…”
Section: Discussionmentioning
confidence: 99%
“…At lower infectious doses, the proportion of diseased animals drops, as well as the severity of the disease. A dose of 10 3 given intratracheally induces normal pathology when assessed 4e5 months after infection [7,10,11]. Intratonsillar exposure is commonly used because of its technical convenience in combination with the fact that it still induces lesions that are comparable to what is seen in natural infections [12].…”
Section: Exposure and Infectious Dosementioning
confidence: 99%
“…Another study observed that a low dose of BCG vaccine favors a TH1 type of immune response vs. a TH2 type of response in Balb/c mice (14); TH1 type responses are considered to favor enhanced protective immunity against intracellular parasites, most convincingly in the case of Leishmania. Finally, several studies of BCG vaccine indicate an absent effect of dose on protective immunity, particularly when the immunizationchallenge interval is greater than 7 weeks (6,12,(15)(16)(17)(18)(19)(20)(21). Whatever the relationship between dose and efficacy of wild-type BCG, whether a more potent recombinant BCG vaccine would exhibit the same dose-efficacy relationship was not known before the present study.…”
Section: Introductionmentioning
confidence: 99%